Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


Cancer-causing GE Therapies: Urgent Need for Tools

Cancer- causing GE Therapies Signal Urgent Need for Diagnostic Tools


Animal studies have shown that a form of gene therapy, previously believed to be successful, has actually caused cancer. This indicates that tests evaluating the impact of genetic engineering (GE) techniques on people are essential.

The latest findings show that scientists do not yet understand the full complexities of gene function and regulation and that GE foods as well as medicines may cause unexpected harm.

"New diagnostic tools are urgently needed so that medical professionals can identify whether an illness is being caused by genetic alterations made to food or as part of gene-based therapy," says Claire Bleakley, president of GE Free NZ in food and environment.

The discovery that GE medicines may also cause harm, including creating cancer, is regarded as a call for greater scrutiny of the widely used, but uncontrolled use of GE technology on populations around the world.

A GE drug which was trialled in the UK earlier this year caused horrific responses in the test 'patients' and almost caused the death of a young New Zealander. Yet the drug manufacturers and regulatory authorities have said very little about the drug being a product of genetic engineering.

"Doctors are also being left in the dark about the possible impact of GE foods that may have been consumed. This gap should have been closed years ago, given that government officials are allowing GE food into the food chain," says Mrs. Bleakley. "But shamefully, it has not been closed."

GE medicines are bound by a regulations much stricter than those controlling GE food. "This should be of great concern to the officials and politicians who have allowed GE ingredients into everything from babyfood to tampons," said Ms Bleakley. "It is a scandal only now coming to light that this has taken place without proper testing, tracking or diagnostic tools to limit the long-term harm that genetic engineering technology could be causing."


ENDS

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Onetai Station: Overseas Investment Office Puts Ceol & Muir On Notice

The Overseas Investment Office (OIO) has issued a formal warning to Ceol & Muir and its owners, Argentinian brothers Rafael and Federico Grozovsky, for failing to provide complete and accurate information when they applied to buy Onetai Station in 2013. More>>

ALSO:

Tomorrow, The UN: Feds President Takes Reins At World Farming Body

Federated Farmers president Dr William Rolleston has been appointed acting president of the World Farmers’ Organisation (WFO) at a meeting in Geneva overnight. More>>

ALSO:

I Sing The Highway Electric: Charge Net NZ To Connect New Zealand

BMW is turning Middle Earth electric after today announcing a substantial contribution to the charging network Charge Net NZ. This landmark partnership will enable Kiwis to drive their electric vehicles (EVs) right across New Zealand through the installation of a fast charging highway stretching from Kaitaia to Invercargill. More>>

ALSO:

Watch This Space: Mahia Rocket Lab Launch Site Officially Opened

Economic Development Minster Steven Joyce today opened New Zealand’s first orbital launch site, Rocket Lab Launch Complex 1, on the Mahia Peninsula on the North Island’s east coast. More>>

Earlier:

Marketing Rocks!
Ig Nobel Award Winners Assess The Personality Of Rocks

A Massey University marketing lecturer has received the 2016 Ig Nobel Prize for economics for a research project that asked university students to describe the “brand personalities” of three rocks. More>>

ALSO:

Nurofen Promotion: Reckitt Benckiser To Plead Guilty To Misleading Ads

Reckitt Benckiser (New Zealand) intends to plead guilty to charges of misleading consumers over the way it promoted a range of Nurofen products, the Commerce Commission says. More>>

ALSO:

Get More From Scoop

 
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news